Astellas Pharma and Sanwa Kagaku Kenkyusho (SKK) will launch ARGAMATE 89.29% Granule 5.6g hyperkalemia therapy on 11 January 2013 in Japan. ARGAMATE Granule is indicated for the treatment of hyperkalemia resulting from acute or chronic ...
Tags: Astellas, hyperkalemia therapy, chronic renal failure, drug